Abstract: The invention relates to compounds corresponding to formula (I): in which R2 and R3 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: in which the wavy lines represent the phenyl nucleus to which R2 and R3 are attached. Preparation process and therapeutic use.

Abstract: A bearing assembly comprises a bearing enabling a rotatable body to rotate about a rotational axis relative to a stationary body. The bearing includes a bearing inner ring and a bearing outer ring, each having at least first and second roller body tracks provided in or on non-parallel surfaces of the ring. The respective roller body tracks of the bearing outer ring are aligned with the respective roller body tracks of the bearing inner ring and a row of roller bodies is disposed between each of the respective sets of roller body tracks. At least one of the rows of roller bodies comprises one of tapered rollers and spherical rollers, at least one of the rows of roller bodies supports at least axial forces and at least one of the rows of the roller bodies supports at least radial forces.

Abstract: The invention relates to new sulphonylaminopyrrolidinone compounds having antithrombotic activity which, in particular, inhibit blood clotting factor IXa and/or factor Xa, to processes for their preparation and to use thereof as drugs.

Abstract: The invention relates to new sulphonylaminopyrrolidinone compounds having antithrombotic activity which, in particular, inhibit blood clotting factor IXa and/or factor Xa, to processes for their preparation and to use thereof as drugs.

Abstract: The invention relates to compounds corresponding to formula (I): in which R2 and R3 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: in which the wavy lines represent the phenyl nucleus to which R2 and R3 are attached. Preparation process and therapeutic use.

Abstract: The invention relates to compounds corresponding to formula (I): in which R2 and R3 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: in which the wavy lines represent the phenyl nucleus to which R2 and R3 are attached. Preparation process and therapeutic use.

Abstract: The invention relates to compounds corresponding to formula (I): in which R2 and R3 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: in which the wavy lines represent the phenyl nucleus to which R2 and R3 are attached. Preparation process and therapeutic use.

Abstract: The present invention relates to compounds of formula I, The compounds of formula I are valuable pharmacologically active compounds. They exhibit a strong anti-thrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardio-vascular disorders like thromboembolic diseases or restenoses. They are inhibitors of the blood clotting enzymes, especially factor VIIa and can in general be applied in conditions in which an undesired activity of factor VIIa is present or for the cure or prevention of which an inhibition of factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.

Abstract: A bearing assembly comprises a bearing enabling a rotatable body to rotate about a rotational axis relative to a stationary body. The bearing includes a bearing inner ring and a bearing outer ring, each having at least first and second roller body tracks provided in or on non-parallel surfaces of the ring. The respective roller body tracks of the bearing outer ring are aligned with the respective roller body tracks of the bearing inner ring and a row of roller bodies is disposed between each of the respective sets of roller body tracks. At least one of the rows of roller bodies comprises one of tapered rollers and spherical rollers, at least one of the rows of roller bodies supports at least axial forces and at least one of the rows of the roller bodies supports at least radial forces.

Abstract: The present invention relates to compounds of formula I, The compounds of formula I are valuable pharmacologically active compounds. They exhibit a strong anti-thrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardio-vascular disorders like thromboembolic diseases or restenoses. They are inhibitors of the blood clotting enzymes, especially factor VIIa and can in general be applied in conditions in which an undesired activity of factor VIIa is present or for the cure or prevention of which an inhibition of factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.

Abstract: The invention relates to a bicycloazaheterocyclyl carboxylic acid sulfonamide derivative of formula I herein, pharmaceutical preparation comprising it, process for preparing it and method for its pharmaceutical use.

Abstract: The invention therefore relates to compounds of the formula I in which the variables are as defined in the specification, to pharmaceutical compositions containing them and to their use for therapeutically lowering blood glucose levels.

Abstract: A wind power plant comprises an outside ring, an inside ring and roll bodies arranged between an inside jacket of the outside ring and an outside jacket of the inside ring for permitting twisting or rotation of the bearing rings against one another. One of the rings on the jacket comprises an auxiliary sensor at least along a portion of the periphery. The auxiliary sensor together with the primary sensor provided in the other bearing ring are configured in such a way that a twisting or rotational position of the two bearing rings relative to one another can be detected.

Abstract: The invention relates to compounds of formula (I), where the groups have the meanings set forth herein and the physiologically-acceptable salts thereof. The compounds are suitable as medicaments for lowering blood sugar levels and for prevention and treatment of diabetes.

Abstract: The invention therefore relates to compounds of the formula I in which the variables are as defined in the specification, to pharmaceutical compositions containing them and to their use for therapeutically lowering blood glucose levels.

Abstract: The invention relates to compounds of formula (I), where the groups have the meanings set forth herein and the physiologically-acceptable salts thereof. The compounds are suitable as medicaments for lowering blood sugar levels and for prevention and treatment of diabetes.

Abstract: Pyrimidine-4,6-dicarboxylic acid diamides of the formula I are suitable for selectively inhibiting collagenase (MMP 13). The pyrimidine-4,6-dicarboxylic acid diamides can therefore be used for treating degenerative joint diseases.

Abstract: The invention relates to a bicycloazaheterocyclyl carboxylic acid sulfonamide derivative of formula I herein, pharmaceutical preparation comprising it, process for preparing it and method for its pharmaceutical use.

Abstract: A wind power plant comprises an outside ring, an inside ring and roll bodies arranged between an inside jacket of the outside ring and an outside jacket of the inside ring for permitting twisting or rotation of the bearing rings against one another. One of the rings on the jacket comprises an auxiliary sensor at least along a portion of the periphery. The auxiliary sensor together with the primary sensor provided in the other bearing ring are configured in such a way that a twisting or rotational position of the two bearing rings relative to one another can be detected.

Abstract: Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides of formula I. These compounds are found to possess the property of selectively inhibiting collagenase (MMP). They may therefore be useful in prophylaxis and therapy of diseases whose course involves an increased activity of matrix metalloproteinase 13.